BioXcel Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTAI and other ETFs, options, and stocks.About BTAI
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions.
CEOVimal D. Mehta
CEOVimal D. Mehta
Employees37
Employees37
HeadquartersNew Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded2017
Founded2017
Employees37
Employees37
BTAI Key Statistics
Market cap36.30M
Market cap36.30M
Price-Earnings ratio-0.18
Price-Earnings ratio-0.18
Dividend yield—
Dividend yield—
Average volume420.33K
Average volume420.33K
High today$1.70
High today$1.70
Low today$1.65
Low today$1.65
Open price$1.68
Open price$1.68
Volume332.05K
Volume332.05K
52 Week high$9.26
52 Week high$9.26
52 Week low$1.17
52 Week low$1.17
Stock Snapshot
With a market cap of 36.3M, BioXcel Therapeutics(BTAI) trades at $1.66. The stock has a price-to-earnings ratio of -0.18.
As of 2025-12-26, BioXcel Therapeutics(BTAI) stock has fluctuated between $1.65 and $1.70. The current price stands at $1.66, placing the stock +0.6% above today's low and -2.4% off the high.
BioXcel Therapeutics(BTAI) shares are trading with a volume of 332.05K, against a daily average of 420.33K.
During the past year, BioXcel Therapeutics(BTAI) stock moved between $1.17 at its lowest and $9.26 at its peak.
During the past year, BioXcel Therapeutics(BTAI) stock moved between $1.17 at its lowest and $9.26 at its peak.
People also own
Based on the portfolios of people who own BTAI. This list is generated using Robinhood data, and it’s not a recommendation.